Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Inventory: 2017-2024

Historic Inventory for RedHill Biopharma (RDHL) over the last 8 years, with Dec 2024 value amounting to $3.7 million.

  • RedHill Biopharma's Inventory fell 16.69% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.2 million, marking a year-over-year decrease of 16.69%. This contributed to the annual value of $3.7 million for FY2024, which is 16.81% down from last year.
  • RedHill Biopharma's Inventory amounted to $3.7 million in FY2024, which was down 16.81% from $4.4 million recorded in FY2023.
  • RedHill Biopharma's Inventory's 5-year high stood at $11.0 million during FY2022, with a 5-year trough of $3.7 million in FY2024.
  • Over the past 3 years, RedHill Biopharma's median Inventory value was $4.4 million (recorded in 2023), while the average stood at $6.3 million.
  • Its Inventory has fluctuated over the past 5 years, first surged by 246.76% in 2020, then slumped by 60.13% in 2023.
  • RedHill Biopharma's Inventory (Yearly) stood at $6.5 million in 2020, then increased by 17.99% to $7.7 million in 2021, then soared by 42.97% to $11.0 million in 2022, then plummeted by 60.13% to $4.4 million in 2023, then declined by 16.81% to $3.7 million in 2024.